Enhertu Breast Cancer Drug Results in ‘Unheard-of’ Survival Rates

The patients had metastatic breast cancer that had been progressing despite rounds of harsh chemotherapy. But a treatment with a drug that targeted cancer cells with laserlike precision was stunningly successful, slowing tumor growth and extending life to an extent seen with advanced cancers. The new study, presented at the annual meeting of the American … Read more

Pharma giants take on Appalachian cancer rates in newest screening initiative

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Two portraits, or perhaps stereotypes, of rural Appalachia exist. One conjures images of winding country roads connecting idyllic Leave-It-To-Beaver towns hidden in the shadows of rugged mountain ranges. The other brings to mind rusted suspension bridges, buckling … Read more

A Cancer Trial’s Unexpected Result: Remission in Every Patient

It was a small trial, just 18 rectal cancer patients, every one of whom took the same drug. But the results were astonishing. The cancer vanished in every single patient, undetectable by physical exam, endoscopy, PET scans or MRI scans. Dr. Luis A. Diaz Jr. of Memorial Sloan Kettering Cancer Center, an author of a … Read more

New Developments in Gynecological Cancer Research

Substantial unmet needs exist in the diagnosis and treatment of gynecologic cancers. Often, these tumors are detected in later stages when treatment options are limited, and prognosis is poor. However, the gynecologic cancer space is on the cusp of change. The recent introduction of novel medicines, namely targeted therapies, has improved patient care and outcome. … Read more